TP53 and colorectal carcinoma: Altogether, IBMZC had a stimulatory effect on the pro-apoptotic BAX and TP53 gene expression levels and an inhibitory effect on the anti-apoptotic BCL-2 and BCL-xL gene expression levels in both CRC cells, in a dose-dependent manner (Figure 5).